Pseudomyogenic Hemangioendothelioma With Novel <i>NEDD9::FOSB</i> Fusion Gene

Pseudomyogenic hemangioendothelioma (PMHE) is a rare, low-grade vascular neoplasm that presents cutaneously as erythematous papules or nodules. Diagnosis is challenging, as PMHE can mimic more common benign dermatological conditions and shares histological similarities with high-grade tumors, particularly epithelioid sarcoma. We present the case of an 18-year-old male with a two-year history of a tender, indurated, dark brown subcutaneous plaque on his right upper thigh with histopathologic features consistent with PMHE. Genetic testing revealed a novel gene fusion, NEDD9::FOSB, which has not previously been reported in the literature, adding to the current genetic understanding of PMHE, and warrants further exploration as a potential therapeutic target.

Authors

Institutions

Publication Details

Journal
Pediatric Dermatology
Published
2026-03-26
DOI
https://doi.org/10.1111/pde.70190
Primary Topic
Vascular Tumors and Angiosarcomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pseudomyogenic Hemangioendothelioma With Novel NEDD9::FOSB Fusion Gene

Archana Shenoy, Suchita Sampath, Ashlie Rubrecht, Jennifer H. Aldrink et al.
Pediatric Dermatology
Vascular Tumors and Angiosarcomas
article

Pseudomyogenic Hemangioendothelioma With Novel NEDD9::FOSB Fusion Gene

Archana Shenoy, Suchita Sampath, Ashlie Rubrecht, Jennifer H. Aldrink, Esteban Fernández Faith, Cathleen D'Angelo
article en

Abstract

Pseudomyogenic hemangioendothelioma (PMHE) is a rare, low-grade vascular neoplasm that presents cutaneously as erythematous papules or nodules. Diagnosis is challenging, as PMHE can mimic more common benign dermatological conditions and shares histological similarities with high-grade tumors, particularly epithelioid sarcoma. We present the case of an 18-year-old male with a two-year history of a tender, indurated, dark brown subcutaneous plaque on his right upper thigh with histopathologic features consistent with PMHE. Genetic testing revealed a novel gene fusion, NEDD9::FOSB, which has not previously been reported in the literature, adding to the current genetic understanding of PMHE, and warrants further exploration as a potential therapeutic target.

Pediatric Dermatology
Nationwide Children's Hospital (US), Riverside Methodist Hospital (US), Ohio University (US), The Ohio State University (US)
Openalex Percentile: Top 7%
Vascular Tumors and Angiosarcomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pseudomyogenic Hemangioendothelioma With Novel <i>NEDD9::FOSB</i> Fusion Gene — Archana Shenoy, Suchita Sampath, et al. · Pediatric Dermatology (2026) | TGRS Research Map | TGRS